Blood sampling to assess production of antigen-specific antibodies after immunization is commonly performed, but it presents logistical difficulties for trials carried out during an infectious disease outbreak. In this study, we show that antibodies may be reliably detected in oral fluid collected in a minimally invasive manner without use of sharps. Clinical Trials Registration. NCT02240875
Sporadic outbreaks of Ebolavirus infection have been documented since the mid-seventies and viral ex...
BACKGROUND: Without an effective vaccine, as was the case early in the 2014-2016 Ebola Outbreak in W...
Ebola virus (EBOV) caused more than 11,000 deaths during the 2013-2016 epidemic in West Africa witho...
Blood sampling to assess production of antigen-specific antibodies after immunization is commonly pe...
Background. Patients who have refused to provide blood samples has meant that there have been signif...
Summary: Background: Ebola virus (EBOV) vaccines containing glycoprotein (GP) provide protection ag...
Background Ebola virus (EBOV) neutralizing antibody in plasma may reduce viral load following admini...
BACKGROUND: The frequency of asymptomatic infection with Ebola virus is unclear: previous estimates ...
As the most advanced Ebola virus vaccine candidate, recombinant vesicular stomatitis virus–Zaire Ebo...
BACKGROUND: The frequency of asymptomatic infection with Ebola virus is unclear: previous estimates ...
Ebola virus (EBOV) represents a major concern to global health due to the unpredictable nature of ou...
The need for an efficacious vaccine against highly pathogenic filoviruses was reinforced by the deva...
Ebola virus disease causes widespread and highly fatal epidemics in human populations. Today, there ...
Antibody titers against a viral pathogen are typically measured using an antigen binding assay, such...
International audienceOBJECTIVES: For Ebola vaccine development, antibody response is a major endpoi...
Sporadic outbreaks of Ebolavirus infection have been documented since the mid-seventies and viral ex...
BACKGROUND: Without an effective vaccine, as was the case early in the 2014-2016 Ebola Outbreak in W...
Ebola virus (EBOV) caused more than 11,000 deaths during the 2013-2016 epidemic in West Africa witho...
Blood sampling to assess production of antigen-specific antibodies after immunization is commonly pe...
Background. Patients who have refused to provide blood samples has meant that there have been signif...
Summary: Background: Ebola virus (EBOV) vaccines containing glycoprotein (GP) provide protection ag...
Background Ebola virus (EBOV) neutralizing antibody in plasma may reduce viral load following admini...
BACKGROUND: The frequency of asymptomatic infection with Ebola virus is unclear: previous estimates ...
As the most advanced Ebola virus vaccine candidate, recombinant vesicular stomatitis virus–Zaire Ebo...
BACKGROUND: The frequency of asymptomatic infection with Ebola virus is unclear: previous estimates ...
Ebola virus (EBOV) represents a major concern to global health due to the unpredictable nature of ou...
The need for an efficacious vaccine against highly pathogenic filoviruses was reinforced by the deva...
Ebola virus disease causes widespread and highly fatal epidemics in human populations. Today, there ...
Antibody titers against a viral pathogen are typically measured using an antigen binding assay, such...
International audienceOBJECTIVES: For Ebola vaccine development, antibody response is a major endpoi...
Sporadic outbreaks of Ebolavirus infection have been documented since the mid-seventies and viral ex...
BACKGROUND: Without an effective vaccine, as was the case early in the 2014-2016 Ebola Outbreak in W...
Ebola virus (EBOV) caused more than 11,000 deaths during the 2013-2016 epidemic in West Africa witho...